Cite

HARVARD Citation

    Jafaripour, S. et al. (2020). In silico drug repositioning of FDA-approved drugs to predict new inhibitors for alpha-synuclein aggregation. Computational biology and chemistry. p. . [Online]. 
  
Back to record